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ABSTRACT
Gene expression control largely depends on ribonu-
cleoprotein complexes regulating mRNA translation.
Initiation of translation in mRNAs that overcome
cap-dependent translation inhibition is often driven
by internal ribosome entry site (IRES) elements,
whose activity is regulated by multifunctional RNA-
binding factors. Here we show that Gemin5 interacts
preferentially with a specific domain of a viral IRES
consisting of a hairpin flanked by A/U/C-rich se-
quences. RNA-binding assays using purified
proteins revealed that Gemin5–IRES interaction
depends on the C-terminal region of the protein.
Consistent with this novel finding, the C-terminal
region of Gemin5, but not the N-terminal region,
impaired translation. Furthermore, RNA selective
20hydroxyl acylation analysed by primer extension
(SHAPE) reactivity demonstrated that addition of
purified Gemin5 to IRES mRNA induced the specific
protection of residues around the hairpin of the IRES
element. We further demonstrate that Gemin5
out-competed SHAPE reactivity variations induced
by the IRES-binding factor PTB, leading to a local
conformational change in the IRES structure.
Together, our data unveil the inhibitory mechanism
of Gemin5 on IRES-mediated translation.
INTRODUCTION
RNA-binding proteins play a crucial role in gene expres-
sion control in all organisms. In eukaryotic cells, a large
variety of ribonucleoprotein complexes affect the process-
ing, transport, localization, translation and decay of
mRNAs (1–5). Thus, RNA-binding proteins are respon-
sible for the establishment and regulation of RNA–protein
networks that determine the target mRNA fate. The un-
translated regions (UTR) of mRNAs play a key role in
many of these processes, serving as platforms for the
assembly of macromolecular complexes particularly
those controlling translation initiation (6).
Initiation of translation in eukaryotic mRNAs involves
a group of specialized proteins, known as initiation factors
(eIFs) that recruit the small ribosome subunit to the
m7GpppN residue (or cap) located at the 50-end of most
mRNAs (7). However, strong cellular stresses (including
viral infection, cell death, nutrient deprivation, heat-
shock, oxidative stress, DNA damage, among others)
repress cap-dependent initiation of translation. Thereby,
cap-independent mechanisms have been exploited by
mRNAs translated under these situations (8–10).
Initiation of translation in some viral RNAs, exempliﬁed
by picornaviruses, is governed by internal ribosome entry
site (IRES) elements (11). In addition to a subset of eIFs,
IRES-dependent translation of viral and cellular mRNAs
depends on host factors termed IRES transacting factors
(ITAFs) (12–16). ITAFs are RNA-binding proteins that
regulate RNA lifespan as part of macromolecular
complexes operating either in the nucleus or in the cyto-
plasm of the cell (17,18). However, the mode of action
used by distinct ITAFs to regulate the activity of different
IRES elements remains unclear.
Using riboproteomic approaches, we identiﬁed Gemin5
as one of the proteins that has the capacity to bind viral
IRES elements (19). The interaction of Gemin5 with the
IRES elements of foot-and-mouth disease virus (FMDV)
and hepatitis C virus (HCV) was direct, as shown by
immunoprecipitation of photo-crosslinked RNA–protein
complexes (20). Functional analysis addressing the role of
Gemin5 showed that this factor down-regulated IRES
activity and adversely affected cap-dependent initiation,
suggesting that this protein acts as a general down-
regulator of translation (20). Subsequently, Gemin5 was
reported to photocrosslink to 7-methylguanosine (21), and
more recently, Gemin5 was included in the mRNA
interactome list (22). Together, these ﬁndings revealed a
multifunctional role for the Gemin5 protein, acting on
translation control beyond its previously described role
in small nuclear ribonucleoproteins (snRNP) biogenesis
(23,24). Because a signiﬁcant fraction of Gemin5 is
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present in the cell cytoplasm not associated with the
survival of motor neurons (SMN) complex (25,26), it
could be envisioned that Gemin5 performs unanticipated
functions in gene expression control. However, how this
protein recognizes distinct RNA targets and whether this
function resides in different domains of the protein
remains elusive.
Gemin5 is proteolysed in FMDV-infected cells; this
event depends on the expression of L protease and takes
place at similar times as cleavage of other RNA-binding
proteins such as poly(A)-binding protein (PABP) and
polypyrimidine-binding protein (PTB) (27). Notably,
Gemin3 cleavage has also been reported to occur during
enterovirus infection (28), suggesting that inactivation of
the SMN complex may be a general feature of picorna-
virus infections.
Here we uncover the mechanism by which Gemin5
interacts with the IRES element and represses translation.
We have found that the C-terminal region of Gemin5 is
responsible for the IRES recognition interacting with the
most 30 end domain of the IRES element, upstream of
the initiator codon. Furthermore, we show that the
C-terminal region of Gemin5 acts as a translation repres-
sor; this property is achieved by the capacity of Gemin5 to
interfere with PTB, one of the RNA-binding proteins
interacting with this IRES region (19,29,30). In agreement
with these results, selective 20 hydroxyl acylation analysed
by primer extension (SHAPE) RNA reactivity assays
demonstrated that the binding of Gemin5 to the IRES
element speciﬁcally induced the protection of residues
within domain 5 and, interestingly, out-competed with
the effects of PTB on SHAPE reactivity.
MATERIALS AND METHODS
Constructs
Plasmids expressing different domains of FMDV IRES
element were described (29,31). Domain 5 mutants were
ampliﬁed with the sense primers d5II-wt, d5II-base, or
d5II-stem (Supplementary Table S1), in conjunction with
SP6 primer. PCR products were digested with EcoRI and
BamHI and ligated into pGEM3 vector, similarly treated.
Construct 5-rest, restoring the proximal stem of the hair-
pin, was performed by PCR mutagenesis using primers
sd5IIbase and asd5IIrest (Supplementary Table S1) with
pGEM-d5 wt as template, followed by a second PCR with
asd5II, and inserted into the EcoRI/XhoI sites of pGEM.
Construct 5-U/A was performed by overlapping PCR
using the pair of primers sd5IIwt, asd5IIU/A and
sd5IIU/A, asd5II (Supplementary Table S1) with pGEM-
d5II template. The PCR product was inserted into the
pGEM vector by EcoRI/BamHI digestion. Constructs
5-sm and 5-scr were generated using primers sd5IIsm and
asd5II, or sd5IIscr and asd5II, respectively. PCR products
were inserted into the EcoRI site of pGEM.
Mutagenesis of the IRES element present in the pBIC
construct (expressing the bicistronic RNA CAT—FMDV
IRES—luciferase) to insert the sm and scr substitutions
was performed using the Quickchange mutagenesis pro-
cedure (Agilent Technologies) with the pair o primers
sId5-sm, asId5-sm, and sId5-scr, asId5-scr, respectively
(Supplementary Table S1). All plasmids were sequenced
to ensure correctness.
The construct pRSETBG5-13WD, encoding His-Xpress
tagged G5-13WD protein, was generated from an inter-
mediate construct (pRSETBG5.1) that contained nt
1-2273 from pcDNA3.1D-Gemin5 V5/His (20) ﬂanked by
BamHI restriction sites, followed by insertion of the
SalI-EcoRI 1811 nt fragment from pcDNA3.1D-Gemin5
V5/His into pRSETBG5.1. The construct expressing
His-Xpress tagged G5-Cter protein was generated using
primers sG5.1EcoRI and asG5EcoRI, and pcDNA3.1D-
Gemin5 V5/His template. This product (nt 3859 to 4527)
was inserted into the EcoR1 site of pRSETB. The construct
pRSETBG5, expressing His-Xpress Gemin5 protein, was
generated by insertion of the EcoR1 fragment from
pRSETBG5-Cter into pRSETBG5-13WD. The construct
pGEMG5-Cter was generated by amplifying the entire
Gemin5-coding region from pcDNA3.1D-Gemin5 V5/His
using primers sG5.2Eco and asG5SalI, and inserted into
EcoRI/SalI sites of pGEM. The nt sequence of all con-
structs was veriﬁed by sequencing (Macrogen).
RNA synthesis
Transcription was performed for 1 h at 37C using 1000–
3000U of T7 RNA polymerase with 10–15 mg of linearized
DNA, 40mM Tris-HCl, 50mM DTT, 0.5mM rNTPs, as
described (32). When needed, transcripts were uniformly
labeled using a32P-CTP (500Ci/mmol) with 10U of T7
RNA polymerase and 1 mg of linearized plasmid (33).
RNA was extracted with phenol–chloroform, ethanol
precipitated and resuspended in 10mM Tris, pH 8,
1mM EDTA (TE) to a concentration of 0.04 pmol/ml.
RNA integrity was examined in 6% acrylamide, 7M
urea denaturing gel electrophoresis.
Domain 5 RNAs were generated from pGEM-d5IIwt,
5-base, 5-rest, 5-U/A, 5-stem, 5-sm and 5-scr constructs
linearized with XhoI. Monocistronic RNA was prepared
from pIC plasmid (34) linearized with BbuI prior to
generate an RNA encompassing the IRES element
linked to ﬁreﬂy luciferase. Bicistronic RNAs [chloram-
phenicol acetyl transferase (CAT)—IRES—luciferase
(LUC)] were produced as described (35). To obtain
RNAs expressing G5-13WD or G5-Cter, plasmids
pRSETBG513WD and pGEMG5Cter were linearized
with XbaI or SalI, respectively.
Expression and puriﬁcation of proteins
Escherichia coli BL21 bacteria transformed with plasmids
pRSETBG5, G5-13WD or G5-Cter were grown in
autoinduction medium (36) overnight at 37C. Bacterial
cell lysates were prepared in binding buffer (20mM
NaH2PO4, 500mM NaCl, 20mM Imidazol) using a
French press, and cell debris was eliminated by centrifu-
gation at 16000g 30min at 4C twice. The lysate was
loaded in His-GraviTrap columns (HealthCare), and the
recombinant protein was eluted using Imidazol 500mM.
Recombinant 6x-His tagged PTB was similarly puriﬁed
using Ni-agarose columns. Proteins were dialysed
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against phosphate buffer pH 6.8, 1mM DTT, and stored
at 20C in 50% glycerol.
RNA–Gemin5 binding assays
Protein G-agarose/Xpress/Gemin5 complexes were assem-
bled by incubating protein G-agarose beads (30 ml)
(SIGMA), pre-cleared four times with PBS, with the
anti-Xpress antibody (200 ng) (Invitrogen) overnight at
4C in a rotating wheel. Unbound antibody was
removed by washing four times in cold BBH buffer
(10mM HEPES; pH 7.4, 100mM NaCl, 2.5mM MgCl2,
0.01% NP-40), prior to resuspending the beads in 400 ml of
BBH buffer. Then, 100 ml aliquots of antibody beads were
incubated with, or without, Gemin5 or G5-13WD or
G5-Cter (0.7 pmol) in the presence of 100-fold excess of
BSA during 4 h at 4C in a rotating wheel. Unbound
proteins were removed by washing four times with cold
BBH buffer. 32P-labelled domain 5 RNA (120 fmol) was
added to each protein-beads complex and incubated in
cold BBH buffer in the presence of cytoplasmic RNA
(200-fold excess), during 2 h at 4C in a rotating wheel.
Unbound RNA was removed by washing four times with
cold BBH buffer. Bound RNAs were extracted with
phenol–chloroform, ethanol precipitated, and fractionated
by 6% acrylamide, 7M urea denaturing gel electrophor-
esis, and visualized by autoradiography.
RNA–protein photocrosslinking and immunodetection
BHK-21 cytoplasmic cell extract was prepared as descri-
bed (37). Uniformly radiolabelled probes (0.04 pmol,
5 105 cpm) were incubated with S10 cell extracts
(40 mg total protein) or puriﬁed proteins (50–200 ng) and
UV-irradiated in the presence of 1000-fold molar excess of
total cytoplasmic RNA (20). Following extensive RNase
treatment, samples were subjected to 8% SDS-PAGE, and
32P-labelled proteins were visualized by autoradiography.
For immunoprecipitation of RNA–protein complexes,
pre-cleared protein A-sepharose beads (SIGMA) were
incubated with Gemin5 antibody (Bethyl) overnight at
4C in a rotating wheel. Unbound antibody was
removed, and the beads were incubated with the RNA–
protein UV-crosslinking products (20). Unbound proteins
were removed by washing four times with radioimmuno-
precipitation assay (RIPA) buffer and once with PBS.
Bound proteins were fractionated by 8% SDS-PAGE.
Gemin5 was immunodetected by western blot as
described (27) using anti-Gemin5 antibody (Novus).
Secondary antibodies (Thermo Scientiﬁc) were used ac-
cording to the manufacturer instructions.
In vitro translation
G5-13WD and G5-Cter transcripts (0.03–0.45 pmols)
synthesized in vitro were translated in 70% rabbit reticu-
locyte lysate (RRL) (Promega) supplemented with
35S-methionine (10 mCi) 15min prior to addition of the
bicistronic RNA (200 ng) bearing the FMDV IRES, as
described (27).
IRES activity assays
Relative IRES activity was quantiﬁed as the expression of
luciferase normalized to that of CAT from bicistronic
mRNAs as described (34) in transfected BHK-21 mono-
layers. Experiments were performed on triplicate wells,
and each experiment was repeated at least three times.
SHAPE RNA probing in the presence and absence of
IRES-bindings factors
RNA–protein complexes were assembled in folding buffer
(100mM HEPES pH 8.0, 6mM MgCl2, 100mM NaCl)
using 0.17mM RNA (38) in the presence of increasing
amounts of HIS-tagged PTB (100, 500 or 900 nM),
Gemin5 or the C-terminal region of Gemin5 (15, 75, or
750 nM) during 10min at room temperature. Then, RNA
alone or preincubated with the protein of interest was
treated with N-methylisatoic anhydride (NMIA) (39).
For RNA–protein complexes assembled using two
proteins, the lowest concentration of each protein render-
ing a protection pattern was used to add increasing
concentrations of the other factor. Brieﬂy, a constant con-
centration of PTB (500 nM) was incubated with RNA in
the presence of Gemin5 (75 or 300 nM). Conversely, a
constant concentration of Gemin5 (75 nM) was incubated
with RNA in the presence of PTB (500 or 900 nM).
For primer extension, equal amounts of NMIA-treated
and untreated RNAs (10 ml) were incubated with 0.5ml of
the appropriate antisense 50 end 32P-labelled primer (50 CT
ACGAAGCAACAGTG, 50 CCCGGGTGTGGGTACC,
50 GGAATGGGATCCTCGAGCTCAGGGTC, 50 GGC
CTTTCTTTATGTTTTTGGCG). Primer extension was
conducted in a ﬁnal volume of 15 ml containing reverse
transcriptase (RT) buffer (50mM Tris HCl pH 8.3,
3mM MgCl2, 75mM KCl, 8mM DTT) and 1mM of
each dNTP. The mix was heated at 52C for 1min, prior
to addition of 100 U of Superscript III RT (Invitrogen)
and incubation at 52C for 30min. cDNA products were
fractionated in 6% acrylamide, 7M urea gels, in parallel
to a sequence obtained with the same primer (38).
Data from two independent assays were used to calcu-
late the mean SHAPE reactivity. For this, the intensity of
each RT-stop band was normalized to the total intensity
of the gel lane made relative to the corresponding full-
length product intensity (set to 100%). Then, the back-
ground values of the untreated RNA (NMIA) were sub-
tracted from the respective RT-stop intensity yielded by
the treated RNA (NMIA+). To obtain SHAPE differ-
ences in RNA–protein complexes, the SHAPE reactivity
values obtained in the samples incubated with free RNA
were subtracted from the reactivity values obtained in the
presence of protein, run in parallel.
RESULTS
Gemin5 protein speciﬁcally binds to domain 5 of the IRES
We have shown that Gemin5 binds to the FMDV IRES
(20). However, neither the target region within the IRES
element that provides the binding site for Gemin5 nor the
region of the protein responsible for the IRES interaction
was known. To identify the binding site of Gemin5 within
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the IRES element, we generated transcripts corresponding
to separate IRES domains, termed 1-2, 3, 4-5, 5, 5-H and
5-ss (Figure 1A). These transcripts were used as probes to
perform photocrosslinking assays, by incubating
32P-labelled RNAs with soluble cell extracts, a method
that reveals factors covalently linked to the probe
(Figure 1B). Polypeptides p220, p120 and p80 interacting
with the FMDV IRES have been previously identiﬁed as
eIF4G, eIF3b/c and eIF4B, respectively (29). The 170 kDa
protein that corresponds to Gemin5 (20) interacted with
domain 5. Dissection of domain 5 into the hairpin (5-H)
and the single stranded region (5-ss) indicated that 5-H
contained the preferential binding site of p170, while the
probe 5-ss barely interacted with it (Figure 1C). In
contrast, the entire domain 5 was required to detect efﬁ-
cient p80 crosslinking.
To verify whether the UV-crosslinked polypeptides cor-
responded to Gemin5, we conducted immunoprecipitation
assays with anti-Gemin5 antibody (Figure 1D). Notably,
the p170 product was detected with probes 5 and 5-H. In
both cases, failure of p80 immunoprecipitation conﬁrmed
the assay speciﬁcity. Furthermore, no immunopre-
cipitation products were detected with probes 1-2 and
5-ss. We conclude that Gemin5 speciﬁcally binds to the
hairpin of domain 5 within the IRES element.
Systematic mutagenesis of domain 5 reveals that Gemin5
binding allows RNA sequence ﬂexibility
Domain 5 consists of a hairpin of nine base pairs, followed
by a single-stranded region that incorporates a
polypyrimidine-rich sequence (Figure 1E). Covariation
analysis of sequences found in multiple isolates of FMDV
indicated that the stem structure (nt 419–440) is conserved.
In contrast, the most 30 end region of domain 5 is variable
although the pyrimidine tract (nt 438–447) is conserved
(32). Despite this sequence variability, this region partly
mirrors the Sm site of snRNAs, consisting of a 50 AUUU
UUG-30 sequence upstream of a hairpin (23).
Because the 5-H probe consisting uniquely of the hairpin,
but not the 5-ss RNA, was capable of interacting with p170
in a UV-crosslink assay (Figure 1C and D), we determined
the role of the stem in Gemin5–IRES interaction by
destabilizing its RNA structure. A mutant RNA disrupting
the three apical base pairs (5-stem), but retaining the
proximal part of the hairpin (Figure 1E), was not affected
in p170 binding, although a diminished p80 interaction was
detected, in agreement with other mutants altering the
apical loop of domain 5 (29). A mutant disrupting three
base pairs of the proximal region of the hairpin (5-base)
and a second-site mutant aimed to restore RNA structure
(5-rest) did not disable p170 interaction, while p80 binding
was abolished in the 5-base mutant.
We next examined the involvement of residues located
at the 50-end of the hairpin in Gemin5 interaction using
mutants 5-sm and 5-scr (Figure 1F). Notably, interaction
of p170 with these probes was slightly enhanced relative to
the wild type (wt) RNA, while p80 binding was abolished.
Nonetheless, the RNA 5-sm bearing the AAUUUUUGA
sequence was similarly efﬁcient in p170 binding capacity
than the RNA 5-scr, bearing the ACCACGUGA
sequence. To further dissect the residues responsible for
Gemin5 interaction, we generated the mutant 5-U/A
(Figure 1F), bearing ﬁve U residues within the
polypyrimidine tract substituted to A. Compared with
RNA wt, this probe also showed a moderate increase in
its capacity to bind p170, suggesting that the U residues
placed at the 30-end of domain 5 were not a determinant
for the interaction with Gemin5. Together, these results
led us to conclude that interaction of Gemin5 with the
IRES element allows RNA sequence ﬂexibility, in agree-
ment with the sequence variability of FMDV RNA (32).
Notwithstanding, a short hairpin in the context of domain
5 sequence, absent in other IRES regions, is sufﬁcient to
provide a landing pad for this protein.
In support of the biological relevance of Gemin5 inter-
action with the IRES element, bicistronic constructs
bearing the sm or scr substitution exhibited a decreased
IRES activity in transfected BHK-21 cells (Supplementary
Figure S1), with the peculiarity that the IRES element
harbouring the sm substitution was 3-fold more defective
than the one carrying the scr substitution.
Gemin5 directly interacts with the IRES element through
its C-terminal region
Gemin5 is a 170 kDa protein with 13 WD repeats at the
N-terminal region (40). Earlier work has reported that the
ﬁfth WD repeat is responsible for the interaction with the
Sm site of snRNAs (23). As shown above, U-rich se-
quences were not speciﬁcally required for Gemin5 inter-
action with the IRES element. The lack of similarity
between the IRES binding site and the Sm site found in
snRNAs suggested that the region of the protein involved
in IRES interaction could be different.
Thus, to determine the Gemin5 region involved in the
interaction with the IRES element, we generated
His-tagged versions of the protein spanning amino acids
1–1508 (full-length Gemin5), 1–1288 (G5-13WD) and the
C-terminal moiety containing amino acids 1287 to 1508
(G5-Cter). These proteins also contain an Xpress epitope
at the amino-terminal end (Figure 2A). 32P-labelled
domain 5 was incubated with His-tagged puriﬁed
proteins (either Gemin5, G5-13WD or G5-Cter)
immobilized on protein G-agarose beads coupled to
anti-Xpress antibody (Figure 2B). Bound RNAs were
isolated and analysed by denaturing polyacrylamide gel
electrophoresis (Figure 2B). The mobility of the isolated
RNAs was similar to the free probe (lane 1), loaded as Mw
marker. The sample containing RNA incubated with
protein G-agarose/antiXpress beads, but no protein
(lane 2), served as background signal (42% relative to
the signal observed in lane 3 with Gemin5 set at 100%).
Notably, the RNA-binding capacity of the C-terminal
region (G5-Cter) (lane 5, 108%) was similar to that of
the full-length protein (Gemin5) (lane 3), and higher
than that of G5-13WD truncated protein (lane 4, 39%).
This result indicated that the C-terminal region spanning
amino acids 1287 to 1508 of Gemin5 is sufﬁcient to
interact with the FMDV IRES.
To further validate this conclusion, we conducted a
UV-crosslink assay using increasing amounts of puriﬁed
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G5-Cter and 32P-labelled domain 5 (Figure 2C).
A UV-crosslinking product of about 40 kDa, with the
same mobility as the protein analysed by western blot
using anti-Gemin5 antibody, was detected. No
crosslinking products were observed using similar concen-
trations of puriﬁed G5-13WD protein (Supplementary
Figure S2), irrespectively of the addition of S10 BHK-21
cell extracts to the UV-crosslink assay potentially
containing auxiliary factors. Therefore, we conclude that
the C-terminal region of Gemin5 directly interacts with
domain 5 of the IRES element.
The C-terminal region of Gemin5 down-regulates
translation
Gemin5 downregulates translation in tissue cultured cells
as well as in cell free systems (20). To determine whether
Figure 1. Gemin5 binds directly to domain 5 of the FMDV IRES. (A) Secondary structure of the FMDV IRES with indication of structural
domains. Thin lines at the bottom depict the approximate location of transcripts (IRES, 1-2, 3, 4-5, 5, 5-H and 5-ss) used in this work.
(B) UV-crosslinking assay of BHK-21 S10 cell extracts with radiolabelled IRES, or domain 1-2, 3, 4-5 and 5 RNAs. Arrows indicate the
position of p220, p170, p120 and p80 photo-crosslinked products. (C) UV-crosslinking assay of radiolabelled domain 5, domain 5 hairpin (5-H)
and the single-stranded region of domain (5-ss). (D) Immunoprecipitation of Gemin5 from BHK-21 cell extracts photo-crosslinked to radiolabelled
transcripts IRES, 1-2, 5, 5-H and 5-ss. Samples were fractionated on 8% SDS-PAGE. In all cases the input (In) corresponds to 5% of the
immunoprecipitation (IP) sample. (E) Effect of destabilization of the hairpin of domain 5 in protein photocrosslinking. Secondary structure of
wild type (wt) domain 5 (corresponding to probe 5 in Figures 1B–D); substitutions designed to destabilize the hairpin in mutants 5-stem or 5-base,
and to restore the RNA structure in mutant 5-rest are marked with a rectangle (top panel). Autoradiograph of a UV-crosslinking assay carried out
with the indicated 32P-labelled mutant RNAs and BHK-21 S10 extracts, fractionated on SDS-PAGE 8% (bottom panel). Thin lines point to p170,
p120 and p80. (F). Effect of the primary sequence composition within the 50 and 30 region of the hairpin in protein photocrosslinking. Substitutions
designed to modify the primary sequence of the 50 (mutants 5-sm, 5-scr) and 30 sequence (5-U/A) of domain 5 (top panel) are marked with a
rectangle. UV-crosslinking assay of the indicated 32P-labelled mutant RNAs and BHK-21 S10 extracts (bottom panel).
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or not the IRES-binding capacity of the C-terminal region
of Gemin5 correlated with the ability to control trans-
lation, we generated RNAs expressing truncated forms
of the protein from the T7 promoter, one corresponding
to the amino-terminal region of the protein (G5-13WD),
and the other corresponding to the C-terminal region
(G5-Cter). These RNAs were used in in vitro translation
assays to measure their capacity to interfere bicistronic
RNA translation (Figure 3A and B). Of interest, the
13WD polypeptide did not affect the IRES-dependent tra-
nslation efﬁciency of luciferase, while only a very modest
reduction (10%) of CAT synthesis was observed at the
highest concentration of G5-13WD RNA (Figure 3A).
In contrast, expression of the G5-Cter protein induced a
dose-dependent decrease of both, IRES-dependent and
50-end-dependent translation efﬁciency (Figure 3B).
Thus, we conclude that the C-terminal region of Gemin5
is responsible for the translation repression activity of this
RNA-binding protein.
Gemin5 induces the protection of residues belonging to
domain 5 in IRES–protein complexes assembled in vitro
To establish a relationship between RNA–protein inter-
action and repression of IRES activity, we analysed the
changes in local nucleotide ﬂexibility by selective 20-
hydroxyl analysed by primer extension (SHAPE), a meth-
odology that allows the study of long RNA molecules,
either free (41) or assembled in RNA–protein complexes
(42). To this end, RNA encompassing the entire IRES
element was incubated with increasing amounts of
puriﬁed Gemin5 protein prior to NMIA treatment.
Reverse-transcriptase extension analysis (32) allowed the
measurement of SHAPE reactivity of the IRES region on
Figure 2. Identiﬁcation of the Gemin5 region involved in IRES inter-
action. (A) Diagram of the His-tagged Gemin5 proteins used in this
study. Numbers indicate the amino acids encompassed by Gemin5
(full-length protein), G5-13WD (N-terminal region) or G5-Cter
(C-terminal region). The Xpress epitope at the N-terminal end
present in all proteins and the epitope recognized by anti-Gemin5
antibody are depicted by a grey or white diamonds, respectively;
grey ovals depict the 13 WD repeats. (B). Schematic representation
of the RNA-binding assay (top). Dotted circles depict agarose beads
bound to anti-Xpress antibody; Xpress-tagged Gemin5 is depicted by
grey ovals with a grey diamond, radiolabelled RNA is depicted in
black. Autoradiograph of a denaturing 6% acrylamide gel, 7M Urea
loaded with RNAs isolated from protein G-Xpress antibody beads
coupled to the indicated proteins (bottom). (C) UV-crosslinking
(UV-XL) assay conducted with increasing amounts (0 to 200 ng) of
puriﬁed His-tagged G5-Cter and radiolabelled domain 5. The
mobility of the same protein detected by western blot (WB) using
anti-Gemin5 is shown on the right.
Figure 3. The C-terminal region of Gemin5 represses translation.
(A) Increasing amounts of RNA expressing G5-13WD were added to
RRL prior to addition of a bicistronic RNA (200 ng) bearing the
FMDV IRES in the intercistronic region. 35S-labelled proteins were
resolved in 12% SDS-PAGE, and the intensity of 35S-labelled luciferase
(squares) (IRES-dependent translation) and CAT (triangles) (50-end
dependent translation) proteins was measured in a densitometer.
(B) Increasing amounts of an RNA expressing the C-terminal region
of Gemin5 (G5-Cter) were added to RRL prior to addition of a
bicistronic RNA. Values correspond to the mean (SD) of three
assays.
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RNAs incubated, or not, with Gemin5. SHAPE reactivity
reﬂects the intensity of the NMIA-treated RNA primer
extension products, normalized to the corresponding un-
treated RNA, in the presence or absence of different con-
centrations (0, 15, 75 nM) of Gemin5 (Figure 4A).
The SHAPE reactivity values observed with free RNA
were used to compute differences in SHAPE reactivity
observed upon addition of Gemin5 (Figure 4B). Interes-
tingly, speciﬁc RNA residues become protected from
NMIA attack. The protections observed include RNA
regions that report RNA–protein interactions, or changes
in RNA conformation induced by the RNA–protein inter-
action. Upon addition of Gemin5, SHAPE reactivity dif-
ferences revealed a dose-dependent induced protection of
nucleotides spanning domain 5 and the most 30-end of
domain 4 (nt 380–458). Of interest, 75nM Gemin5 was
sufﬁcient to induce the protection of residues belonging
to domain 5. Residues belonging to domains 2 and 3
showed no gross changes in SHAPE differences
(Figure 4B). These results revealed that Gemin5 speciﬁcally
interacts with residues belonging to domain 5, in agreement
with the results shown in Figure 1D.
Similar assays carried out with the C-terminal moiety of
Gemin5 indicated that this region of the protein is sufﬁ-
cient to induce the protection of the sequences that lie
nearest to the 30-end of the IRES (Supplementary Figure
S3), reinforcing the conclusions from data in Figure 2B
and C. Although the protection was less intense than that
Figure 4. Impact of Gemin5 on IRES SHAPE reactivity. (A) RNA SHAPE reactivity as a function of nucleotide position for the free RNA treated
with NMIA is depicted at the top panel. SHAPE reactivity values observed on addition of puriﬁed Gemin5 (15, 75 nM) are shown (top to bottom
panels). Bars are coloured according to reactivity. Numbers depict nucleotides showing larger differences in SHAPE reactivity. (B) SHAPE difference
plots of the IRES RNA incubated with Gemin5 relative to free RNA. Arrows below the bottom panel indicate the border of IRES domains 2, 3, 4
and 5.
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observed with the full-length protein, the protected
residues map to the same IRES region. An increase in
SHAPE reactivity noticed at nt 451 on addition of
G5-Cter was not observed with the entire protein.
The RNA region recognized by Gemin5 in UV-crosslink
assays (Figure 1B and C) overlaps with the binding site of
PTB within the FMDV IRES (29,43). Thereby, the results
shown in Figure 4A prompted us to verify whether or not
the interaction of Gemin5 with the IRES element could
affect the binding of PTB. For this, SHAPE assays were
conducted with increasing concentrations (500 or 900 nM)
of puriﬁed PTB individually (Figure 5A). On addition of
PTB, SHAPE differences relative to the free RNA indicated
that residues preferentially protected from NMIA attack
included positions 417–453 (Figure 5B).
In summary, and relative to the SHAPE reactivity
observed with free RNA (Figure 6), incubation of RNA
with individual proteins led to a decreased SHAPE re-
activity at speciﬁc positions within domains 4 and 5.
Notably nt 380–382, 416–418, 427–432 and 440–458
were protected from NMIA attack upon addition of
Gemin5. These protections partially overlapped with
those observed on incubation of the IRES element with
PTB (Figure 6). Together, the results derived from
SHAPE local nucleotide dynamics allow us to conclude
that residues with decreased ﬂexibility on addition of
Gemin5 partially overlap with those induced by the
IRES-binding protein PTB.
Gemin5 out-competes PTB from its RNA-binding site in
IRES–protein complexes
Next, to evaluate a potential interference between PTB
and Gemin5 in IRES recognition, we conducted SHAPE
reactivity assays of IRES–protein complexes using
Figure 5. Dose-dependent effect of PTB on IRES RNA structure monitored by SHAPE. (A) RNA SHAPE reactivity as a function of nucleotide
position for the free RNA is depicted at the top panel. SHAPE reactivity values observed upon addition of puriﬁed PTB (500, 900 nM) are shown
(top to bottom panels). (B). SHAPE difference plots of the IRES RNA incubated with PTB relative to free RNA. Numbers depict nucleotides
showing larger differences in SHAPE reactivity. Arrows below the bottom panel indicate the border of IRES domains 2, 3, 4 and 5.
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combinations of two factors within a concentration range
previously determined to detect protein-induced RNA
protection (Figures 4 and 5). Supplementary Figure S4
shows a representative example of a SHAPE reactivity
assay using increasing amounts of Gemin5 in the
presence of a constant amount of PTB (lanes 3–7), and
conversely, a ﬁxed amount of Gemin5 in the presence of
increasing concentrations of PTB (lanes 8–12). As
expected, the NMIA-treated RNA (+) (lane 2) in the
absence of proteins showed a marked reactivity
compared with the untreated RNA () (lane 1). This
result denoted the residues with high SHAPE reactivity
using naked RNA (Figure 6).
Quantitative analysis of SHAPE reactivity obtained with
each RNA–protein complex assembly condition was per-
formed to determine the differences in SHAPE reactivity
induced by incubation of the RNA with proteins, relative to
the reactivity of free RNA. SHAPE differences derived
from two independent experiments performed with PTB
and Gemin5 revealed that low amounts of Gemin5
(75nM) interfered with the interaction between PTB
(900nM) and domain 5 (Figure 7A). For simplicity, only
the SHAPE difference proﬁle along IRES nt 300 to 462 is
shown, as no changes in residues belonging to domains 2
and 3 were observed. Addition of higher concentrations of
Gemin5 led to a similar SHAPE difference pattern
(Supplementary Figure S5). On the other hand, a conform-
ational change in RNA structure that exposed the most 30
end residues of the polypyrimidine tract (CUUUACAA)
was observed in both cases (Figure 7B). We conclude that
Gemin5 exerts its inhibitory activity by interfering with the
recognition of the translation activator PTB. Thus, beyond
the well-described SMN complex, Gemin5 forms part of a
ribonucleoprotein complex that controls IRES activity.
Figure 6. Summary of SHAPE reactivity of the IRES element. Nucleotide SHAPE reactivity observed in the free RNA is represented by a coloured
scale (>10, grey, >25, yellow; >50, orange). The nucleotides protected from RNA attack in SHAPE reactivity assays upon addition of Gemin5, or
PTB, are depicted by yellow diamonds and blue rectangles, respectively.
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DISCUSSION
Gemin5 was identiﬁed as the protein that delivers the SMN
complex to the Sm site of snRNAs (23), as an
IRES-binding factor (19) and as a translation down-regu-
lator (20). Here we report three main ﬁndings relevant to
the activity of Gemin5 as a translation regulator. First, we
show that the C-terminal part of Gemin5 possess
RNA-binding capacity being responsible for the interaction
with the 30 end domain of a picornavirus IRES. Second, we
show that the C-terminal region of the protein contributes
to down-regulate translation efﬁciency, and third, we
provide evidence that this may occur through partial com-
petition with PTB for the RNA sequence encompassing
domain 5 of the IRES element.
The RNA-binding capacity of this region of Gemin5 is
a novel ﬁnding. In snRNAs the Gemin5 recognition motif
has been described as a U-rich sequence, usually preceding
a short stem-loop, although some differences exist (44). In
contrast, U-rich sequences are not speciﬁcally required in
the IRES element for Gemin5 binding. Photocrosslinking
assays aided by immunoprecipitation led to the identiﬁca-
tion of domain 5 as the binding site of Gemin5 within the
IRES element. Additionally, an extensive mutational
analysis indicated that binding of Gemin5 allows a large
RNA sequence ﬂexibility. Nonetheless, a common feature
of snRNAs and the IRES-binding site found here is the
presence of a short hairpin ﬂanked by sequences rich in
A/U/C residues. This feature has been shown in high
throughput sequencing analysis of novel snRNAs precur-
sors bound to Gemin5 (26). Reinforcing this conclusion,
substitution of ﬁve Us by As in domain 5 slightly
enhanced Gemin5 interaction, and RNAs having either
an Sm-like or a scrambled sequence in the 50 end region
exhibited similar binding capacity. Nevertheless, other
IRES domains containing hairpins were not effective
binding sites of Gemin5, indicating that not any
stem-loop RNA structure provides a recognition motif
for the protein.
As demonstrated by UV crosslinking and RNA-binding
assays, the C-terminal region of Gemin5 is sufﬁcient to
bind directly to domain 5. The RNA-binding capacity of
this region was unexpected, as no apparent similarity has
been detected between the Gemin5 C-terminal region and
known RNA-binding motifs. The C-terminal RNA-
binding region differs from that described in earlier
studies that identiﬁed the WD repeats domain as the
region responsible for snRNA interaction (45). Differe-
nces in amino acid composition and, likely, in structural
organization of these distant regions of Gemin5 may
explain the diversity of RNA motifs recognized by the
N-terminal, containing the 13WD repeats, or the
C-terminal region of the protein.
Functional analysis involving expression of the protein
in cell-free systems provided insights into the mechanism
conferring its translation control capacity. The repressor
effect of Gemin5 in mRNA translation, although moder-
ate, is consistent with its capacity to compete for the
RNA-binding site in the IRES element with PTB.
Besides, incubation of Gemin5 and PTB with the
FMDV IRES reorganized the local RNA structure of
this region, resulting in a modiﬁed SHAPE reactivity of
the region immediately upstream of the functional start
codon. Gemin5 translational control may become signiﬁ-
cant in the context of a competitive environment, a
Figure 7. Modiﬁcation of the difference in SHAPE reactivity induced upon addition of Gemin5 and PTB. (A) SHAPE difference proﬁles of the
IRES incubated with Gemin5 (75 nM), PTB (900 nM), alone or combined, relative to free RNA. The RNA region where most of the rearrangements
are observed upon addition of the proteins is highlighted by a dotted rectangle. (B) Schematic representation of the Gemin5 (yellow) and PTB (blue)
individual binding sites and the conformational reorganization of domain 5 (highlighted with arrows) induced by the combined addition of both
proteins (grey).
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situation that is compromised during picornavirus infec-
tion. In this regard, we have recently reported that
Gemin5 is proteolysed during FMDV infection (27).
Gemin5 proteolysis occurred at similar times that PABP
or PTB, and later than eIF4G cleavage, presumably
contributing to inhibit cellular gene expression by
eIF4G-independent mechanisms.
Gemin5 is found mainly in the cell cytoplasm (46) and a
signiﬁcant amount is not associated to other Gemins or
SMN complex (25). Indeed, proteomic analysis of the
SMN complex revealed that Gemin5 is a peripheral
protein (47). Consistent with this ﬁnding, the SMN
complex has been described as a dynamic system contain-
ing a large number of factors (48). The presence of free
Gemin5 in the cell cytoplasm is congruent with a multi-
functional role of this protein. Hence, it is likely that
Gemin5 may recruit (or interfere with) other factors that
also have mRNA-binding capacity and thus, regulate
translation. Importantly, we have discovered that
Gemin5 directly binds to a speciﬁc region of the IRES,
and it is able to out-compete ITAFs that recognize the
same region. Several alternative though not mutually ex-
clusive possibilities may explain this property. One is the
existence of similar recognition motifs in the competitor
proteins despite no canonical RNA recognition motifs
have been detected in the C-terminal region of Gemin5.
The second one could be potential protein–protein inter-
actions preventing the interaction of ITAFs with the IRES
element. Following on this, interactions of Gemin5 with
other RNA-binding proteins have been described, as
illustrated by hnRNP U or eIF4E (20,49). hnRNP U is
a RGG protein that interacts with the SMN protein (50)
and coimmunoprecipitates with Gemin5 crosslinked to
HCV and FMDV IRES (20). Conversely, proteins
coimmunoprecipitating with hnRNP U included Gemin5
and eIF4E. Furthermore, M7GTP pull-down assays
resulted in the isolation of eIF4E, Gemin5 and hnRNP
U, but not PTB, irrespectively of the presence of viral
IRES RNA (20), suggesting that interference with PTB
is unrelated to protein–protein interaction. A third possi-
bility could be that the RNA-binding sites of the competi-
tor proteins are closely located leading to steric
interference or to conformational changes in RNA struc-
ture. Our results of Gemin5–PTB interference, which
promote a local RNA structure reorganization detected
by the SHAPE nucleotide dynamics assay, favour the
latter possibility. Our ﬁndings will be instrumental to de-
termine the role of Gemin5, and Gemin5-associated
partners, in translation initiation driven by other IRES
elements, in particular, and translation control in general.
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